_id
69148e54ccc777a4e85d9b28
Ticker
PLRX
Name
Pliant Therapeutics Inc
Exchange
NASDAQ
Address
331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://pliantrx.com
Description
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Last Close
1.32
Volume
1315271
Current Price
1.23
Change
-6.818181818181824
Last Updated
2025-12-03T12:10:26.076Z
Image
-
Ipo Date
2020-06-03T00:00:00.000Z
Market Cap
91559584
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.964
Sentiment Sources
3
Rating
3.2308
Target Price
3.25
Strong Buy
1
Buy
1
Hold
11
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
28269000
Operating Income
-28269000
Interest Expense
2783000
Pretax Income
-26301000
Net Income
-26301000
Eps
-0.42830988100196277
Dividends Per Share
-
Shares Outstanding
61449385
Income Tax Expense
-
EBITDA
-23082000
Operating Margin
-
Total Other Income Expense Net
1968000
Cash
93732000
Short Term Investments
148065000
Receivables
908000
Inventories
-
Total Current Assets
245588000
Property Plant Equipment
29138000
Total Assets
276600000
Payables
485000
Short Term Debt
1187000
Long Term Debt
30439000
Total Liabilities
76294000
Equity
200306000
Depreciation
436000
Change In Working Capital
-1849000
Cash From Operations
-21081000
Capital Expenditures
0
Cash From Investing
27921000
Cash From Financing
72000
Net Change In Cash
6912000
PE
-
PB
0.37707289971343844
ROE
-13.130410471977875
ROA
-9.508676789587852
FCF
-21081000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
5.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
28269000
Quarters > 0 > income Statement > operating Income
-28269000
Quarters > 0 > income Statement > interest Expense
2783000
Quarters > 0 > income Statement > pretax Income
-26301000
Quarters > 0 > income Statement > net Income
-26301000
Quarters > 0 > income Statement > eps
-0.42830988100196277
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
61406475
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-23082000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1968000
Quarters > 0 > balance Sheet > cash
93732000
Quarters > 0 > balance Sheet > short Term Investments
148065000
Quarters > 0 > balance Sheet > receivables
908000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
245588000
Quarters > 0 > balance Sheet > property Plant Equipment
29138000
Quarters > 0 > balance Sheet > total Assets
276600000
Quarters > 0 > balance Sheet > payables
485000
Quarters > 0 > balance Sheet > short Term Debt
1187000
Quarters > 0 > balance Sheet > long Term Debt
30439000
Quarters > 0 > balance Sheet > total Liabilities
76294000
Quarters > 0 > balance Sheet > equity
200306000
Quarters > 0 > cash Flow > net Income
-26301000
Quarters > 0 > cash Flow > depreciation
436000
Quarters > 0 > cash Flow > change In Working Capital
-1849000
Quarters > 0 > cash Flow > cash From Operations
-21081000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
27921000
Quarters > 0 > cash Flow > cash From Financing
72000
Quarters > 0 > cash Flow > net Change In Cash
6912000
Quarters > 0 > ratios > PE
-0.42830988100196277
Quarters > 0 > ratios > PB
0.37707289971343844
Quarters > 0 > ratios > ROE
-13.130410471977875
Quarters > 0 > ratios > ROA
-9.508676789587852
Quarters > 0 > ratios > FCF
-21081000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
447000
Quarters > 1 > income Statement > gross Profit
-447000
Quarters > 1 > income Statement > operating Expenses
45145000
Quarters > 1 > income Statement > operating Income
-45592000
Quarters > 1 > income Statement > interest Expense
809000
Quarters > 1 > income Statement > pretax Income
-43300000
Quarters > 1 > income Statement > net Income
-43300000
Quarters > 1 > income Statement > eps
-0.7053704577135868
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
61386183
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-42044000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2292000
Quarters > 1 > balance Sheet > cash
86820000
Quarters > 1 > balance Sheet > short Term Investments
176053000
Quarters > 1 > balance Sheet > receivables
1535000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
267444000
Quarters > 1 > balance Sheet > property Plant Equipment
30507000
Quarters > 1 > balance Sheet > total Assets
299824000
Quarters > 1 > balance Sheet > payables
1384000
Quarters > 1 > balance Sheet > short Term Debt
1225000
Quarters > 1 > balance Sheet > long Term Debt
30360000
Quarters > 1 > balance Sheet > total Liabilities
79742000
Quarters > 1 > balance Sheet > equity
220082000
Quarters > 1 > cash Flow > net Income
-43300000
Quarters > 1 > cash Flow > depreciation
447000
Quarters > 1 > cash Flow > change In Working Capital
-6920000
Quarters > 1 > cash Flow > cash From Operations
-40603000
Quarters > 1 > cash Flow > capital Expenditures
112000
Quarters > 1 > cash Flow > cash From Investing
35487000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-5116000
Quarters > 1 > ratios > PE
-0.7053704577135868
Quarters > 1 > ratios > PB
0.3430766945502131
Quarters > 1 > ratios > ROE
-19.674484964694976
Quarters > 1 > ratios > ROA
-14.441805859437537
Quarters > 1 > ratios > FCF
-40715000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
448000
Quarters > 2 > income Statement > gross Profit
-448000
Quarters > 2 > income Statement > operating Expenses
58935000
Quarters > 2 > income Statement > operating Income
-58935000
Quarters > 2 > income Statement > interest Expense
799000
Quarters > 2 > income Statement > pretax Income
-56166000
Quarters > 2 > income Statement > net Income
-56166000
Quarters > 2 > income Statement > eps
-0.9174051784342129
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
61222676
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-54919000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2769000
Quarters > 2 > balance Sheet > cash
91936000
Quarters > 2 > balance Sheet > short Term Investments
213709000
Quarters > 2 > balance Sheet > receivables
1683000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
311191000
Quarters > 2 > balance Sheet > property Plant Equipment
31670000
Quarters > 2 > balance Sheet > total Assets
344770000
Quarters > 2 > balance Sheet > payables
5622000
Quarters > 2 > balance Sheet > short Term Debt
771000
Quarters > 2 > balance Sheet > long Term Debt
30284000
Quarters > 2 > balance Sheet > total Liabilities
87606000
Quarters > 2 > balance Sheet > equity
257164000
Quarters > 2 > cash Flow > net Income
-56166000
Quarters > 2 > cash Flow > depreciation
448000
Quarters > 2 > cash Flow > change In Working Capital
-4234000
Quarters > 2 > cash Flow > cash From Operations
-48864000
Quarters > 2 > cash Flow > capital Expenditures
262000
Quarters > 2 > cash Flow > cash From Investing
69114000
Quarters > 2 > cash Flow > cash From Financing
498000
Quarters > 2 > cash Flow > net Change In Cash
20748000
Quarters > 2 > ratios > PE
-0.9174051784342129
Quarters > 2 > ratios > PB
0.29282439019458395
Quarters > 2 > ratios > ROE
-21.840537555800967
Quarters > 2 > ratios > ROA
-16.29086057371581
Quarters > 2 > ratios > FCF
-49126000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2270000
Quarters > 3 > income Statement > cost Of Revenue
1135000
Quarters > 3 > income Statement > gross Profit
1135000
Quarters > 3 > income Statement > operating Expenses
53320000
Quarters > 3 > income Statement > operating Income
-53320000
Quarters > 3 > income Statement > interest Expense
834000
Quarters > 3 > income Statement > pretax Income
-49732000
Quarters > 3 > income Statement > net Income
-49732000
Quarters > 3 > income Statement > eps
-0.8214918739749005
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
60538639
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-48440000
Quarters > 3 > income Statement > operating Margin
-2348.898678414097
Quarters > 3 > income Statement > total Other Income Expense Net
3588000
Quarters > 3 > balance Sheet > cash
71188000
Quarters > 3 > balance Sheet > short Term Investments
284536000
Quarters > 3 > balance Sheet > receivables
2302000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
362264000
Quarters > 3 > balance Sheet > property Plant Equipment
32768000
Quarters > 3 > balance Sheet > total Assets
396949000
Quarters > 3 > balance Sheet > payables
5960000
Quarters > 3 > balance Sheet > short Term Debt
542000
Quarters > 3 > balance Sheet > long Term Debt
30211000
Quarters > 3 > balance Sheet > total Liabilities
92868000
Quarters > 3 > balance Sheet > equity
304081000
Quarters > 3 > cash Flow > net Income
-49732000
Quarters > 3 > cash Flow > depreciation
458000
Quarters > 3 > cash Flow > change In Working Capital
-8181000
Quarters > 3 > cash Flow > cash From Operations
-47662000
Quarters > 3 > cash Flow > capital Expenditures
209000
Quarters > 3 > cash Flow > cash From Investing
39132000
Quarters > 3 > cash Flow > cash From Financing
102000
Quarters > 3 > cash Flow > net Change In Cash
-8428000
Quarters > 3 > ratios > PE
-0.8214918739749005
Quarters > 3 > ratios > PB
0.244877272733252
Quarters > 3 > ratios > ROE
-16.3548528188213
Quarters > 3 > ratios > ROA
-12.528561603631703
Quarters > 3 > ratios > FCF
-47871000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-21.088546255506607
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2125000
Annuals > 0 > income Statement > gross Profit
-2125000
Annuals > 0 > income Statement > operating Expenses
228365000
Annuals > 0 > income Statement > operating Income
-228365000
Annuals > 0 > income Statement > interest Expense
3024000
Annuals > 0 > income Statement > pretax Income
-210304000
Annuals > 0 > income Statement > net Income
-210304000
Annuals > 0 > income Statement > eps
-3.4738805409880458
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
60538639
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-205155000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
18061000
Annuals > 0 > balance Sheet > cash
71188000
Annuals > 0 > balance Sheet > short Term Investments
284536000
Annuals > 0 > balance Sheet > receivables
2302000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
362264000
Annuals > 0 > balance Sheet > property Plant Equipment
32768000
Annuals > 0 > balance Sheet > total Assets
396949000
Annuals > 0 > balance Sheet > payables
5960000
Annuals > 0 > balance Sheet > short Term Debt
542000
Annuals > 0 > balance Sheet > long Term Debt
30211000
Annuals > 0 > balance Sheet > total Liabilities
92868000
Annuals > 0 > balance Sheet > equity
304081000
Annuals > 0 > cash Flow > net Income
-210304000
Annuals > 0 > cash Flow > depreciation
2125000
Annuals > 0 > cash Flow > change In Working Capital
9089000
Annuals > 0 > cash Flow > cash From Operations
-155503000
Annuals > 0 > cash Flow > capital Expenditures
3848000
Annuals > 0 > cash Flow > cash From Investing
140340000
Annuals > 0 > cash Flow > cash From Financing
23117000
Annuals > 0 > cash Flow > net Change In Cash
7954000
Annuals > 0 > ratios > PE
-3.4738805409880458
Annuals > 0 > ratios > PB
0.29663994827036216
Annuals > 0 > ratios > ROE
-69.16051972994038
Annuals > 0 > ratios > ROA
-52.980105756658915
Annuals > 0 > ratios > FCF
-159351000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1580000
Annuals > 1 > income Statement > cost Of Revenue
1841000
Annuals > 1 > income Statement > gross Profit
1580000
Annuals > 1 > income Statement > operating Expenses
185725000
Annuals > 1 > income Statement > operating Income
-184145000
Annuals > 1 > income Statement > interest Expense
1267000
Annuals > 1 > income Statement > pretax Income
-161336000
Annuals > 1 > income Statement > net Income
-161336000
Annuals > 1 > income Statement > eps
-2.7475905916310035
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
58719083
Annuals > 1 > income Statement > income Tax Expense
1673105
Annuals > 1 > income Statement > EBITDA
-158228000
Annuals > 1 > income Statement > operating Margin
-11654.746835443038
Annuals > 1 > income Statement > total Other Income Expense Net
22809000
Annuals > 1 > balance Sheet > cash
63234000
Annuals > 1 > balance Sheet > short Term Investments
431011000
Annuals > 1 > balance Sheet > receivables
2997000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
505502000
Annuals > 1 > balance Sheet > property Plant Equipment
4778000
Annuals > 1 > balance Sheet > total Assets
512154000
Annuals > 1 > balance Sheet > payables
4531000
Annuals > 1 > balance Sheet > short Term Debt
1318000
Annuals > 1 > balance Sheet > long Term Debt
10054000
Annuals > 1 > balance Sheet > total Liabilities
38578000
Annuals > 1 > balance Sheet > equity
473576000
Annuals > 1 > cash Flow > net Income
-161336000
Annuals > 1 > cash Flow > depreciation
1841000
Annuals > 1 > cash Flow > change In Working Capital
1251000
Annuals > 1 > cash Flow > cash From Operations
-116361000
Annuals > 1 > cash Flow > capital Expenditures
921000
Annuals > 1 > cash Flow > cash From Investing
-127012000
Annuals > 1 > cash Flow > cash From Financing
274405000
Annuals > 1 > cash Flow > net Change In Cash
31032000
Annuals > 1 > ratios > PE
-2.7475905916310035
Annuals > 1 > ratios > PB
0.18474634202324441
Annuals > 1 > ratios > ROE
-34.06760477726912
Annuals > 1 > ratios > ROA
-31.501462450747237
Annuals > 1 > ratios > FCF
-117282000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-74.22911392405064
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
9685000
Annuals > 2 > income Statement > cost Of Revenue
3681000
Annuals > 2 > income Statement > gross Profit
9685000
Annuals > 2 > income Statement > operating Expenses
136885000
Annuals > 2 > income Statement > operating Income
-127200000
Annuals > 2 > income Statement > interest Expense
791000
Annuals > 2 > income Statement > pretax Income
-123321000
Annuals > 2 > income Statement > net Income
-123321000
Annuals > 2 > income Statement > eps
-2.9351025806701596
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
42015908
Annuals > 2 > income Statement > income Tax Expense
-1823000
Annuals > 2 > income Statement > EBITDA
-118849000
Annuals > 2 > income Statement > operating Margin
-1313.3711925658235
Annuals > 2 > income Statement > total Other Income Expense Net
3879000
Annuals > 2 > balance Sheet > cash
33685000
Annuals > 2 > balance Sheet > short Term Investments
297502000
Annuals > 2 > balance Sheet > receivables
3144000
Annuals > 2 > balance Sheet > inventories
1
Annuals > 2 > balance Sheet > total Current Assets
340311000
Annuals > 2 > balance Sheet > property Plant Equipment
9908000
Annuals > 2 > balance Sheet > total Assets
350613000
Annuals > 2 > balance Sheet > payables
1580000
Annuals > 2 > balance Sheet > short Term Debt
2457000
Annuals > 2 > balance Sheet > long Term Debt
9929000
Annuals > 2 > balance Sheet > total Liabilities
37271000
Annuals > 2 > balance Sheet > equity
313342000
Annuals > 2 > cash Flow > net Income
-123321000
Annuals > 2 > cash Flow > depreciation
1823000
Annuals > 2 > cash Flow > change In Working Capital
4217000
Annuals > 2 > cash Flow > cash From Operations
-94631000
Annuals > 2 > cash Flow > capital Expenditures
1760000
Annuals > 2 > cash Flow > cash From Investing
-150204000
Annuals > 2 > cash Flow > cash From Financing
226854000
Annuals > 2 > cash Flow > net Change In Cash
-17981000
Annuals > 2 > ratios > PE
-2.9351025806701596
Annuals > 2 > ratios > PB
0.19979352566843897
Annuals > 2 > ratios > ROE
-39.35667736849832
Annuals > 2 > ratios > ROA
-35.172968486622004
Annuals > 2 > ratios > FCF
-96391000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-9.952607124419204
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
7572000
Annuals > 3 > income Statement > cost Of Revenue
3204000
Annuals > 3 > income Statement > gross Profit
7572000
Annuals > 3 > income Statement > operating Expenses
27558000
Annuals > 3 > income Statement > operating Income
-19986000
Annuals > 3 > income Statement > interest Expense
272000
Annuals > 3 > income Statement > pretax Income
-19714000
Annuals > 3 > income Statement > net Income
-17907000
Annuals > 3 > income Statement > eps
-0.49954777912138004
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
35846421
Annuals > 3 > income Statement > income Tax Expense
-1807000
Annuals > 3 > income Statement > EBITDA
-18451000
Annuals > 3 > income Statement > operating Margin
-263.946117274168
Annuals > 3 > income Statement > total Other Income Expense Net
272000
Annuals > 3 > balance Sheet > cash
51665000
Annuals > 3 > balance Sheet > short Term Investments
148931000
Annuals > 3 > balance Sheet > receivables
2466000
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
209441000
Annuals > 3 > balance Sheet > property Plant Equipment
10936000
Annuals > 3 > balance Sheet > total Assets
221215000
Annuals > 3 > balance Sheet > payables
2971000
Annuals > 3 > balance Sheet > short Term Debt
1869000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
22156000
Annuals > 3 > balance Sheet > equity
199059000
Annuals > 3 > cash Flow > net Income
-97263000
Annuals > 3 > cash Flow > depreciation
1535000
Annuals > 3 > cash Flow > change In Working Capital
6917000
Annuals > 3 > cash Flow > cash From Operations
-75443000
Annuals > 3 > cash Flow > capital Expenditures
1953000
Annuals > 3 > cash Flow > cash From Investing
73699000
Annuals > 3 > cash Flow > cash From Financing
2527000
Annuals > 3 > cash Flow > net Change In Cash
783000
Annuals > 3 > ratios > PE
-0.49954777912138004
Annuals > 3 > ratios > PB
0.26831827392883517
Annuals > 3 > ratios > ROE
-8.995825358310853
Annuals > 3 > ratios > ROA
-8.094839861673032
Annuals > 3 > ratios > FCF
-77396000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-10.22134178552562
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.42830988100196277
Valuation > metrics > PB
0.37707289971343844
Valuation > final Score
70
Valuation > verdict
62.3% Undervalued
Profitability > metrics > ROE
-13.130410471977875
Profitability > metrics > ROA
-10.709399482059384
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.380887242518946
Risk > metrics > Interest Coverage
-10.157743442328423
Risk > final Score
19
Risk > verdict
High
Liquidity > metrics > Current Ratio
146.88277511961724
Liquidity > metrics > Quick Ratio
146.88277511961724
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-165
Prev Risks > 1
-235
Prev Risks > 2
-196
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:01:34.455Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-03
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.4166
Earnings History > 0 > eps Difference
0.4166
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.43
Earnings History > 1 > eps Estimate
-0.56
Earnings History > 1 > eps Difference
0.13
Earnings History > 1 > surprise Percent
23.2143
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.71
Earnings History > 2 > eps Estimate
-0.6595
Earnings History > 2 > eps Difference
-0.0505
Earnings History > 2 > surprise Percent
-7.6573
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.92
Earnings History > 3 > eps Estimate
-0.7469
Earnings History > 3 > eps Difference
-0.1731
Earnings History > 3 > surprise Percent
-23.1758
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.82
Earnings History > 4 > eps Estimate
-0.9552
Earnings History > 4 > eps Difference
0.1352
Earnings History > 4 > surprise Percent
14.1541
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.95
Earnings History > 5 > eps Estimate
-0.97
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
2.0619
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-07
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.92
Earnings History > 6 > eps Estimate
-0.85
Earnings History > 6 > eps Difference
-0.07
Earnings History > 6 > surprise Percent
-8.2353
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-06
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.78
Earnings History > 7 > eps Estimate
-0.77
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-1.2987
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.69
Earnings History > 8 > eps Estimate
-0.81
Earnings History > 8 > eps Difference
0.12
Earnings History > 8 > surprise Percent
14.8148
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.7
Earnings History > 9 > eps Estimate
-0.77
Earnings History > 9 > eps Difference
0.07
Earnings History > 9 > surprise Percent
9.0909
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7
Earnings History > 10 > eps Estimate
-0.71
Earnings History > 10 > eps Difference
0.01
Earnings History > 10 > surprise Percent
1.4085
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-09
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.67
Earnings History > 11 > eps Estimate
-0.67
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.72
Earnings History > 12 > eps Estimate
-0.7
Earnings History > 12 > eps Difference
-0.02
Earnings History > 12 > surprise Percent
-2.8571
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.65
Earnings History > 13 > eps Estimate
-0.74
Earnings History > 13 > eps Difference
0.09
Earnings History > 13 > surprise Percent
12.1622
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-08
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.82
Earnings History > 14 > eps Estimate
-0.81
Earnings History > 14 > eps Difference
-0.01
Earnings History > 14 > surprise Percent
-1.2346
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.78
Earnings History > 15 > eps Estimate
-0.75
Earnings History > 15 > eps Difference
-0.03
Earnings History > 15 > surprise Percent
-4
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.68
Earnings History > 16 > eps Estimate
-0.76
Earnings History > 16 > eps Difference
0.08
Earnings History > 16 > surprise Percent
10.5263
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.75
Earnings History > 17 > eps Estimate
-0.69
Earnings History > 17 > eps Difference
-0.06
Earnings History > 17 > surprise Percent
-8.6957
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.64
Earnings History > 18 > eps Estimate
-0.67
Earnings History > 18 > eps Difference
0.03
Earnings History > 18 > surprise Percent
4.4776
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.64
Earnings History > 19 > eps Estimate
-0.6
Earnings History > 19 > eps Difference
-0.04
Earnings History > 19 > surprise Percent
-6.6667
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-16
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.54
Earnings History > 20 > eps Estimate
-0.71
Earnings History > 20 > eps Difference
0.17
Earnings History > 20 > surprise Percent
23.9437
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-11-10
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.47
Earnings History > 21 > eps Estimate
-0.85
Earnings History > 21 > eps Difference
0.38
Earnings History > 21 > surprise Percent
44.7059
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-11
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.39
Earnings History > 22 > eps Estimate
-0.77
Earnings History > 22 > eps Difference
-0.62
Earnings History > 22 > surprise Percent
-80.5195
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-06-03
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.2
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-07-17
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.21
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.21
Earnings History > 24 > surprise Percent
-
Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company's lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages - MarketBeat
12/11/2025
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$3.25
Analyst Picks
Strong Buy
1
Buy
1
Hold
11
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 76.56% of the total shares of Pliant Therapeutics Inc
1.
TANG CAPITAL MANAGEMENT LLC(9.7739%)
since
2025/06/30
2.
Deep Track Capital, LP(6.4309%)
since
2025/06/30
3.
Morgan Stanley - Brokerage Accounts(6.1146%)
since
2025/06/30
4.
Vanguard Group Inc(4.8908%)
since
2025/06/30
5.
Blue Owl Capital Holdings LP(4.8368%)
since
2025/06/30
6.
UBS Group AG(4.3112%)
since
2025/06/30
7.
Citadel Advisors Llc(3.8377%)
since
2025/06/30
8.
Woodline Partners LP(3.8257%)
since
2025/06/30
9.
Madison Avenue Partners, LP(3.6326%)
since
2025/06/30
10.
TRV GP IV, LLC(3.4744%)
since
2025/06/30
11.
BlackRock Inc(3.4706%)
since
2025/06/30
12.
JPMorgan Chase & Co(3.1902%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(2.854%)
since
2025/07/31
14.
Redmile Group, LLC(2.6594%)
since
2025/06/30
15.
Peapod Lane Capital LLC(1.4559%)
since
2025/06/30
16.
Millennium Management LLC(1.3854%)
since
2025/06/30
17.
Great Point Partners LLC(1.3846%)
since
2025/06/30
18.
Prosight Management, LP(1.3641%)
since
2025/06/30
19.
Monaco Asset Management(1.1442%)
since
2025/06/30
20.
Goldman Sachs Group Inc(0.972%)
since
2025/06/30
21.
Geode Capital Management, LLC(0.949%)
since
2025/06/30
22.
Vanguard Institutional Extnd Mkt Idx Tr(0.9127%)
since
2025/07/31
23.
iShares Biotechnology ETF(0.5223%)
since
2025/08/31
24.
Fidelity Extended Market Index(0.4718%)
since
2025/07/31
25.
Schwab US Small-Cap ETF™(0.4093%)
since
2025/08/30
26.
Vanguard US Value Factor ETF(0.3225%)
since
2025/06/30
27.
BLK CDN MSCI USA Sm Cp Ext ESG Fcs Idx A(0.2227%)
since
2025/03/31
28.
iShares Micro-Cap ETF(0.2106%)
since
2025/08/31
29.
Vanguard Health Care ETF(0.1864%)
since
2025/07/31
30.
Extended Equity Market Fund K(0.169%)
since
2025/06/30
31.
Fidelity Total Market Index(0.1556%)
since
2025/07/31
32.
Bridgeway Ultra-Small Company Market(0.1341%)
since
2025/06/30
33.
AST T. Rowe Price Asset Allocation(0.1284%)
since
2024/11/30
34.
Fidelity Series Total Market Index(0.125%)
since
2025/07/31
35.
Invesco RAFI US 1500 Small-Mid ETF(0.1132%)
since
2025/08/29
36.
NT Ext Equity Mkt Idx Fd - NL(0.1096%)
since
2025/06/30
37.
Spartan Extended Market Index Pool F(0.1074%)
since
2025/07/31
38.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.1041%)
since
2025/03/31
39.
Northern Trust Extended Eq Market Idx(0.099%)
since
2025/06/30
40.
NT Ext Equity Mkt Idx Fd - L(0.099%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.4166
Date
2025-09-30
EPS Actual
-0.43
EPS Estimate
-0.56
EPS Difference
0.13
Surprise Percent
23.2143%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.